← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 13, 2021Last known activity
Mar 31, 2023
Timeline
2010s
- Jun 1, 2014
Elucida Oncology— Founded
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (3)
- NCT05622591Lead sponsorPhase 1Mar 31, 2023
- NCT05001282Lead sponsorPhase 1/Phase 2Sep 13, 2021
- NCT05001282Study directorPhase 1/Phase 2Sep 13, 2021
Details
- Founded
- New York, NY, US Jun 1, 2014
- Last known activity
- Mar 31, 2023